Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Advanced Enzyme Technologies Ltd.	LIVE QUOTES

NSE: ADVENZYMESEQ BSE: 540025ISIN: INE837H01020INDUSTRY: Pharmaceuticals

BSE

Rs 325.70

Open: 320.65

Today's Range 319.15

328.00

NSE
Rs 326.65
+5.15 (+ 1.58 %)

+4.20 (+ 1.29 %)

Prev Close: 321.50

52 Week Range 257.85

571.15

Registered Address

Registered Office : A - Wing, Sun Magnetica, 5th Floor, LIC Service Road, Louiswadi,

Thane, Maharashtra - 400604

Tel: 022-41703200

Fax: 022-25835159

Email : info@advancedenzymes.com

Website : http://www.advancedenzymes.com

Key Officials

Name	Designation
Mr. Sanjay Basantani	Company Secretary & Head - Legal
Mr. Beni Prasad Rauka	Chief Financial Officer
Mr. Dipak Roda	Senior Vice President

Listings

BSE , NSE ,

StandaloneConsolidated

Quarterly Trends - Standalone

Rs. in Crs.

Financial Year	Mar 25	Dec 24	Sep 24
Sales	87.21	100.87	77.38
Other Income	4.53	1.43	1.66
Total Expenses	73.04	78.81	63.86
Depreciation	3.11	2.89	2.78
Taxation	4.46	5.36	3.20
Net Profit / Loss	11.05	15.18	9.13
Equity Capital	22.38	22.38	22.37

Half Yearly Balance Sheet - Standalone

Rs. in Crs.

YearEnding	Mar 25	Mar 24	Mar 23
Face Value	2	2	2
Equity Share Capital	22.38	22.37	22.37
Reserves and Surplus	606.97	558.11	502.97
Total Non-Current Liabilities	14.59	12.45	13.57
Total Current Liabilities	44.70	40.01	36.90
Total Capital And Liabilities	688.63	632.93	575.80
Total Non-Current Assets	456.43	384.59	386.66
Total Current Assets	232.20	248.34	189.14
Total Assets	688.63	632.93	575.80

Quarterly Trends - Consolidated

Rs. in Crs.

Financial Year	Mar 25	Dec 24	Sep 24
Sales	167.18	169.11	146.10
Other Income	8.75	7.69	9.62
Total Expenses	121.58	113.85	103.67
Depreciation	10.08	8.97	8.90
Taxation	16.73	14.15	8.82
Net Profit / Loss	26.73	38.88	33.39
Equity Capital	22.38	22.38	22.37

Half Yearly Balance Sheet - Consolidated

Rs. in Crs.

YearEnding	Mar 25	Mar 24	Mar 23
Face Value	2	2	2
Equity Share Capital	22.38	22.37	22.37
Reserves and Surplus	1398.49	1301.76	1212.70
Minority Interest	47.81	46.95	49.10
Total Non-Current Liabilities	55.92	58.03	60.11
Total Current Liabilities	96.76	106.36	77.57
Total Capital And Liabilities	1621.35	1535.46	1421.85
Total Non-Current Assets	741.48	725.72	699.74
Total Current Assets	879.87	809.74	722.11
Total Assets	1621.35	1535.46	1421.85

Corporate News

Accretion Pharma has submitted to BSE the Shareholding Patte...

Accretion Pharma - Outcome of Board Meeting

Registrar Details

MUFG Intime India Pvt. Ltd.

C 101, 247 Park, L.B.S. Marg, Vikhroli (West)

Mumbai,400083,Maharashtra

Tel : 022-49186270

Fax : 49186060

NSE

Market Performance

Exchange		NSE
Last Traded Price (Rs.)		70.30
Last Traded Date		01/07/2025
Last Traded Time		03:09:10 PM
Change (%)		0.43%
Day's Open (Rs.)		71.40
Previous Close (Rs.)		70.00
Day's High (Rs.)		71.40
Day's Low (Rs.)		69.30
Total Traded Qty		8400
Value (Rs. In Lacs)		5.91
Bid Price (Rs.)		69.60
Bid Quantity		1200
Offer Price (Rs.)		71.00
Offer Quantity		1200
Exchange Code		ACCPLSM
Exchange Group		SM

Board Meetings

Date	Purpose
10/06/2025	Audited Results & Others

Share Holding Pattern as on 14/05/2025

Major Holder	No. of Shares	Percentage (%)
Promoters	8,170,000	100.00
Institutional Investors	0	0.00
Other Investors	0	0.00
General Public	0	0.00

Market

Derivatives

Mutual Fund

IPO

Quick Links

Advanced Enzyme Technologies Ltd.

LIVE QUOTES